Robert Torray - Torray Investment Partners
Holding/activity history for Royalty Pharma plc (RPRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 645,425 | 4.85 | Reduce 13.29% | 0.59 | $47.97 | $30,961,051 | SEC |
| 2025 Q4 | 744,355 | 4.41 | Add 5.90% | 0.25 | $38.64 | $28,761,889 | SEC |
| 2025 Q3 | 702,883 | 3.48 | Add 2.05% | 0.07 | $35.28 | $24,797,712 | SEC |
| 2025 Q2 | 688,776 | 3.60 | Reduce 20.10% | 0.80 | $36.03 | $24,816,599 | SEC |
| 2025 Q1 | 862,018 | 4.00 | Add 26.02% | 0.83 | $31.13 | $26,834,620 | SEC |
| 2024 Q4 | 684,007 | 2.50 | Reduce 20.27% | 0.69 | $25.51 | $17,449,019 | SEC |
| 2024 Q3 | 857,919 | 3.40 | Add 23.70% | 0.65 | $28.29 | $24,270,529 | SEC |
| 2024 Q2 | 693,558 | 2.73 | Add 3.51% | 0.09 | $26.37 | $18,289,124 | SEC |
| 2024 Q1 | 670,060 | 3.05 | Add 32.49% | 0.75 | $30.37 | $20,349,722 | SEC |
| 2023 Q4 | 505,740 | 2.30 | Add 22.56% | 0.42 | $28.09 | $14,206,237 | SEC |
| 2023 Q3 | 412,633 | 1.98 | Reduce 0.29% | <0.01 | $27.14 | $11,198,860 | SEC |
| 2023 Q2 | 413,815 | 2.20 | Add 201.68% | 1.47 | $30.74 | $12,720,673 | SEC |
| 2023 Q1 | 137,172 | 0.89 | Reduce 0.14% | <0.01 | $36.03 | $4,942,307 | SEC |
| 2022 Q4 | 137,371 | 0.98 | Reduce 1.19% | 0.01 | $39.52 | $5,428,902 | SEC |
| 2022 Q3 | 139,024 | 1.12 | Add 0.01% | <0.01 | $40.18 | $5,586,000 | SEC |
| 2022 Q2 | 139,012 | 1.12 | Add 5.26% | 0.06 | $42.04 | $5,844,000 | SEC |
| 2022 Q1 | 132,070 | 0.83 | Reduce 4.26% | 0.03 | $38.96 | $5,145,000 | SEC |
| 2021 Q4 | 137,941 | 0.81 | Buy | 0.81 | $39.85 | $5,497,000 | SEC |